Clinical Trial: Clinical and Biological Outcomes of BioBrace-Augmented ACL Reconstruction

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906860) titled 'Clinical and Biological Outcomes of BioBrace-Augmented ACL Reconstruction' on Oct. 15.

Brief Summary: This prospective, single-center, single-arm observational cohort study aims to evaluate the clinical, radiological, and arthroscopic outcomes and safety of primary anterior cruciate ligament (ACL) reconstruction augmented with the BioBrace(R) Reinforced BioInductive Implant. A total of 30 patients who decided to undergo BioBrace-augmented ACL reconstruction in routine clinical practice will be followed for up to 24 months postoperatively. Knee stability, graft maturation via MRI and second-look arthroscopy, patient-reported outcomes...